|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,912.25 GBX | -2.46% |
|
+0.52% | +5.21% |
| 01:09pm | WINNERS & LOSERS: Threat to Vistry; Plus500 plans more share buybacks | AN |
| 08-06 | LifeMine Therapeutics, Inc. announced that it has received $188 million in funding from a group of investors | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GSK PLC | Other Pharmaceuticals | -2.14% | +0.52% | +5.21% | +36.72% | +6.20% | 106B |  | |  |
- Stock Market
- Stocks
- GSK Stock
- Charts GSK plc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
